Related Experiment Video

Updated: Jan 6, 2026

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
07:21

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking

Published on: February 12, 2011

14.8K

Straining the Limits of Sudden Death Risk Stratification: Feature Tracking in HCM

Milind Y Desai1, Susan K Keen1

  • 1Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, Ohio, USA.

JACC. Cardiovascular Imaging
|October 28, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cardiac magnetic resonance imagingglobal longitudinal strainhypertrophic cardiomyopathyrisk stratification

More Related Videos

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
11:13

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging

Published on: May 24, 2021

7.0K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Related Experiment Videos

Last Updated: Jan 6, 2026

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
07:21

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking

Published on: February 12, 2011

14.8K
Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
11:13

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging

Published on: May 24, 2021

7.0K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

465
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
465

Articles linked to this work by shared authors, journal, and citation graph.

Diffuse Fibrosis in Hypertrophic Cardiomyopathy: Incremental Prognostic Value of Extracellular Volume.

JACC. Advances·2026

Gene therapy for hypertrophic cardiomyopathy: From feasibility to a fieldwide framework.

Med (New York, N.Y.)·2026

Rewriting the sarcomere: Gene therapy approaches for hypertrophic cardiomyopathy from bench to bedside.

Med (New York, N.Y.)·2026

Reappraisal of Surgical Threshold in Patients With Ascending Aortic Dilation: Moving Beyond Aortic Diameters?

JACC. Advances·2026

Optimal Reclassification of Aortic Aneurysms: Cross-Sectional CT vs 2D Transthoracic Echocardiography.

JACC. Cardiovascular imaging·2026

Optimizing imaging techniques in hypertrophic cardiomyopathy: challenges and opportunities.

European heart journal. Imaging methods and practice·2026

Incremental Predictive Value of Deep Learning-Quantified Coronary Atherosclerotic Volume: A SCAPIS Cohort Analysis.

JACC. Cardiovascular imaging·2026

Stress Perfusion CMR to Prognosticate for Left Main and High Risk Multivessel Coronary Artery Disease and Major Cardiovascular Adverse Events: Outcomes From a 4,144-Patient Multicenter Cohort.

JACC. Cardiovascular imaging·2026

Ultrasound Cavitation of Microbubbles Augments Limb Perfusion and Promotes Ulcer Healing in Chronic Limb-Threatening Ischemia.

JACC. Cardiovascular imaging·2026

OCT-Defined Plaque Morphology and Clinical Outcomes After Percutaneous Coronary Intervention: An ILUMIEN IV Substudy.

JACC. Cardiovascular imaging·2026

Comparison of Photon-Counting and Energy-Integrating Computed Coronary Tomography Angiography for Coronary Artery Disease: A Systematic Review and Meta-Analysis.

JACC. Cardiovascular imaging·2026

Cardiac MRI-Derived Right Ventricular Strain for Risk Stratification in Pediatric and Adolescent Arrhythmogenic Cardiomyopathy: A Multicenter Cohort Study.

JACC. Cardiovascular imaging·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us